NCEL
NewcelX Ltd.
NASDAQ · Healthcare · Biotechnology · CH
$3.34
−0.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.48x
- Price / sales
- —
- Price / cash flow
- -2.83x
Enterprise value
- Enterprise value
- $16.1M
- EV / sales
- —
- EV / EBITDA
- -2.39x
- EV / EBIT
- -1.57x
- Market cap
- $18.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025